Utility of subcutaneous fat aspiration for diagnosing amyloidosis in patients with isolated peripheral neuropathy

Mayo Clinic Proceedings

Volumn 77, Issue 12, 2002, Pages 1287-1290

  Andrews, Tricia R ^a   Colon Otero, Gerardo ^c   Calamia, Kenneth T ^c   Menke, David M ^c   Boylan, Kevin B ^c   Kyle, Robert A ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; ASPIRATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FAMILY HISTORY; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PARESTHESIA; PERIPHERAL NEUROPATHY; SENSORIMOTOR NEUROPATHY; SUBCUTANEOUS FAT; SYMPTOMATOLOGY;

EID: 0036894468     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/77.12.1287     Document Type: Article

References (14)

1. Kyle RA. Amyloidosis. Circulation. 1995;91:1269-1276.
2. Kyle RA, Gertz MA. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol. 1995;32:45-59.
3. Kelly JJ Jr, Kyle RA, O'Brien PC, Dyck PJ. The natural history of peripheral neuropathy in primary systemic amyloidosis. Ann Neurol. 1979;6:1-7.
4. Gertz MA, Kyle RA. Primary systemic amyloidosis - A diagnostic primer. Mayo Clin Proc. 1989;64:1505-1519.
5. Westermark P, Stenkvist B. A new method for the diagnosis of systemic amyloidosis. Arch Intern Med. 1973;132:522-523.
6. Gertz MA, Li CY, Shirahama T, Kyle RA. Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis (immunoglobulin light chain). Arch Intern Med. 1988;148:929-933.
7. Rappaport WD, Valente J, Hunter GC, et al. Clinical utilization and complications of sural nerve biopsy. Am J Surg. 1993;166:252-256.
8. Gabriel CM, Howard R, Kinsella N, et al. Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry. 2000;69:442-446.
9. Kyle RA, Bayrd ED. Amyloidosis: Review of 236 cases. Medicine (Baltimore). 1975;54:271-299.
10. Benson MD, Cohen AS, Brandt KD, Cathcart ES. Neuropathy, M components, and amyloid. Lancet. 1975;1:10-12.
11. Duston MA, Skinner M, Anderson J, Cohen AS. Peripheral neuropathy as an early marker of AL amyloidosis. Arch Intern Med. 1989;149:358-360.
12. Rajkumar SV, Gertz MA, Kyle RA. Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy. Am J Med. 1998;104:232-237.
13. Ropper AH, Gorson KC. Neuropathies associated with paraproteinemia. N Engl J Med. 1998;338:1601-1607.
14. Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol. 1981;10:222-226.